Suppr超能文献

与反对 COVID-19 疫苗接种证书相关的因素:一项来自亚洲的多国观察性研究。

Factors associated with the opposition to COVID-19 vaccination certificates: A multi-country observational study from Asia.

机构信息

Health Intervention and Technology Assessment Program (HITAP), 6th Floor, 6th Building, Department of Health, Ministry of Public Health, Tiwanon Road, Nonthaburi, 11000, Thailand.

Health Intervention and Technology Assessment Program (HITAP), 6th Floor, 6th Building, Department of Health, Ministry of Public Health, Tiwanon Road, Nonthaburi, 11000, Thailand.

出版信息

Travel Med Infect Dis. 2022 Jul-Aug;48:102358. doi: 10.1016/j.tmaid.2022.102358. Epub 2022 May 18.

Abstract

BACKGROUND

There are ongoing calls to harmonise and increase the use of COVID-19 vaccination certificates (CVCs) in Asia. Identifying groups in Asian societies who oppose CVCs and understanding their reasons can help formulate an effective CVCs policy in the region. However, no formal studies have explored this issue in Asia.

METHOD

The COVID-19 Vaccination Policy Research and Decision-Support Initiative in Asia (CORESIA) was established to address policy questions related to CVCs. An online cross-sectional survey was conducted from June to October 2021 in nine Asian countries. Multivariable logistical regression analyses were performed to identify potential opposers of CVCs.

RESULTS

Six groups were identified as potential opposers of CVCs: (i) unvaccinated (Odd Ratio (OR): 2.01, 95% Confidence Interval (CI): 1.65-2.46); vaccine hesitant and those without access to COVID-19 vaccines; (ii) those not wanting existing NPIs to continue (OR: 2.97, 95% CI: 2.51-3.53); (iii) those with low level of trust in governments (OR: 1.25, 95% CI: 1.02-2.52); (iv) those without travel plans (OR: 1.58, 95% CI: 1.31-1.90); (v) those expecting no financial gains from CVCs (OR: 2.35, 95% CI: 1.98-2.78); and (vi) those disagreeing to use CVCs for employment, education, events, hospitality, and domestic travel.

CONCLUSIONS

Addressing recurring public health bottlenecks such as vaccine hesitancy and equitable access, adherence to policies, public trust, and changing the narrative from 'societal-benefit' to 'personal-benefit' may be necessary and may help increase wider adoption of CVCs in Asia.

摘要

背景

亚洲各地呼吁协调并增加使用 COVID-19 疫苗接种证书(CVC)。了解亚洲社会中反对 CVC 的群体及其原因,有助于制定该地区有效的 CVC 政策。然而,目前在亚洲尚无正式研究探讨这一问题。

方法

为解决与 CVC 相关的政策问题,成立了亚洲 COVID-19 疫苗接种政策研究与决策支持倡议(CORESIA)。2021 年 6 月至 10 月,在亚洲 9 个国家进行了一项在线横断面调查。采用多变量逻辑回归分析确定 CVC 的潜在反对者。

结果

确定了 6 个可能反对 CVC 的群体:(i)未接种疫苗者(比值比(OR):2.01,95%置信区间(CI):1.65-2.46);疫苗犹豫者和无法获得 COVID-19 疫苗者;(ii)那些不希望继续实施现有非药物干预措施的人(OR:2.97,95%CI:2.51-3.53);(iii)对政府信任度低的人(OR:1.25,95%CI:1.02-2.52);(iv)没有旅行计划的人(OR:1.58,95%CI:1.31-1.90);(v)不期望从 CVC 中获得经济利益的人(OR:2.35,95%CI:1.98-2.78);以及(vi)不同意将 CVC 用于就业、教育、活动、酒店和国内旅行的人。

结论

解决疫苗犹豫和公平获取等反复出现的公共卫生瓶颈问题,坚持政策,提高公众信任度,将叙事从“社会效益”转变为“个人效益”,可能是必要的,有助于在亚洲更广泛地采用 CVC。

相似文献

2
Addressing vaccine hesitancy and resistance for COVID-19 vaccines.应对 COVID-19 疫苗的犹豫和抵制。
Int J Nurs Stud. 2022 Jul;131:104241. doi: 10.1016/j.ijnurstu.2022.104241. Epub 2022 Apr 1.
7
The COVID-19 vaccine concerns scale: Development and validation of a new measure.COVID-19 疫苗担忧量表的编制及信效度检验
Hum Vaccin Immunother. 2022 Nov 30;18(5):2050105. doi: 10.1080/21645515.2022.2050105. Epub 2022 Apr 5.

本文引用的文献

2
Vaccine Verification in the COVID-19 World.新冠疫情下的疫苗验证
Lancet Reg Health Am. 2022 Feb;6:100161. doi: 10.1016/j.lana.2021.100161. Epub 2021 Dec 23.
4
Ethical Attitudes toward COVID-19 Passports: Evidences from Spain.对 COVID-19 护照的伦理态度:来自西班牙的证据。
Int J Environ Res Public Health. 2021 Dec 11;18(24):13098. doi: 10.3390/ijerph182413098.
5
Doubt at the core: Unspoken vaccine hesitancy among healthcare workers.核心疑虑:医护人员中未言明的疫苗犹豫情绪
Lancet Reg Health Eur. 2022 Jan;12:100289. doi: 10.1016/j.lanepe.2021.100289. Epub 2021 Dec 14.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验